Hannover, Germany

Wolfgang Loscher

USPTO Granted Patents = 4 


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1999-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wolfgang Loscher - Innovator in Neurological Treatments.

Introduction

Wolfgang Loscher is a notable inventor based in Germany. He has made significant contributions to the field of neurological disorders through his innovative research and development of pharmaceutical compounds. His work focuses on the treatment and prevention of various neurological conditions.

Latest Patents

Wolfgang Loscher holds a patent titled "Use Of 4-(difluoro Methyl)-Pyridin/pyrimidin-2-Amine Compounds For The Treatment Of Neurological Disorders." This invention relates to a compound of formula (I), wherein X1, X2, X3, Y, R1, and R2 are defined within the patent documentation. The compound is intended for use in the prevention or treatment of neurological disorders in subjects. Despite having 4 patents, his research is pivotal in advancing therapeutic options.

Career Highlights

Throughout his career, Wolfgang Loscher has focused on developing innovative solutions for complex medical challenges. His dedication to research has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of neurology.

Collaborations

Wolfgang has collaborated with notable colleagues, including Denise Rageot and Paul Hebeisen. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the treatment of neurological disorders.

Conclusion

Wolfgang Loscher's work exemplifies the importance of innovation in addressing neurological disorders. His contributions, although currently limited in patent count, reflect a commitment to improving patient outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…